glp-1 receptor agonist and dpp-4 inhibitor combination not recommended do combine inhibitors with agonists guidance Why are DPP-4 ( Can patients take GLP-1 and

Beneficial strains include Lactobacillus acidophilus, Bifidobacterium longum, and Akkermansia muciniphila

Reference: Haddad PM et al

In one study, microdosing GLP-1s supported moderate weight loss of up to 10 pounds over 40 weeks in participants. MICRODOSING GLP-1 BENEFITS Do More, Age Less Modulated inflammatory pathways in clinical trials. Studies found a reduced risk of cognitive decline Supported cardiovascular health in clinical trials Improved mitochondrial function and oxidative stress in clinical trials Low doses reduced side effects in clinical trials Supported moderate weight loss of up to 10 pounds over 40 weeks in one study *See studies cited below

Mediators Inflamm (2014) 2014:538737

Posttranslational regulation of Akt in human cancer

Following the absorption of sugar, GLP-1 and GIP secreted by cells of the intestine make it possible to very significantly increase the production of insulin by the pancreas, at levels much higher than those that are produced simply in response to the presence of sugar in the blood (Figure 1)